Prevention of cardiovascular disease in adult recipients of kidney transplants

The Lancet

Volumn 378, Issue 9800, 2011, Pages 1419-1427

  Jardine, Alan G ^a   Gaston, Robert S ^b   Fellstrom, Bengt C ^c   Holdaas, Hallvard ^d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; AZATHIOPRINE; BELATACEPT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; CYTOCHROME P450 3A4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; EZETIMIBE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISOLONE; RAPAMYCIN; SIMVASTATIN; TACROLIMUS; TRIACYLGLYCEROL; UNINDEXED DRUG;

ACUTE GRAFT REJECTION; ADULT; AGING; ALBUMINURIA; ANEMIA; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPLICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; ETHNICITY; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY GRAFT; LIPID BLOOD LEVEL; NEW ONSET DIABETES AFTER TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SMOKING; SMOKING CESSATION; STROKE; UREMIC CARDIOMYOPATHY;

EID: 80054705417     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61334-2     Document Type: Review

References (69)

1. C Baigent, K Burbury, D Wheeler Premature cardiovascular disease in chronic renal failure Lancet 356 2000 147 152 (Pubitemid 30438520)
2. RN Foley, PS Parfrey, MJ Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 5 suppl 3 1998 S112 S119
3. H Ekberg, H Tedesco-Silva, A Demirbas for the ELITE-Symphony Study Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 2007 2562 2754
4. LW Miller Cardiovascular toxicities of immunosuppressive agents Am J Transplant 2 2002 807 818 (Pubitemid 36306835)
5. SR Knight, PJ Morris Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis Transplantation 89 2010 1 14
6. Y Vanrententerghem, B Bresnahan, J Campistol et al. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies) Transplantation 91 2011 976 983
7. CP Larsen, J Grinyó, J Medina-Pestana et al. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies Transplantation 90 2010 1528 1535
8. H Holdaas, B Fellström, AG Jardine et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 2003 2024 2031 (Pubitemid 36695044)
9. H Holdaas, B Fellström, E Cole for the Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study Am J Transplant 5 2005 2929 2936 (Pubitemid 43923954)
10. AK Israni, JJ Snyder, MA Skeans for the PORT Investigators Predicting coronary heart disease after kidney transplantation: patient outcomes in renal transplantation (PORT) study Am J Transplant 10 2010 338 353
11. PB Mark, N Johnston, BA Groenning et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging Kidney Int 69 2006 1839 1845 (Pubitemid 43739213)
12. BL Kasiske, C Guijarro, ZA Massy, MR Wiederkehr, JZ Ma Cardiovascular disease after renal transplantation J Am Soc Nephrol 7 1996 158 165 (Pubitemid 26067103)
13. BL Kasiske, HA Chakkera, J Roel Explained and unexplained ischemic heart disease risk after renal transplantation J Am Soc Nephrol 11 2000 1735 1743
14. C Baigent, MJ Landray, C Reith for the SHARP Investigators The effects of lowering LDL cholesterol with simvastatinplus plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192
15. SA Silver, M Huang, MM Nash, GV Prasad Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients Transplantation 92 2011 183 189
16. AK Israni, JJ Snyder, MA Skeans for the PORT Investigators Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study Am J Transplant 10 2010 338 353
17. HL Pilmore, MA Skeans, JJ Snyder, AK Israni, BL Kasiske Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study Transplantation 91 2011 542 551
18. H Pilmore, H Dent, S Chang, SP McDonald, SJ Chadban Reduction in cardiovascular death after kidney transplantation Transplantation 89 2010 851 857
19. AG Jardine, B Fellström, JO Logan et al. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplant (ALERT) study Am J Kidney Dis 46 2005 529 536 (Pubitemid 41208190)
20. I Soveri, H Holdaas, A Jardine, C Gimpelewicz, B Staffler, B Fellström Renal transplant dysfunction - importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality Nephrol Dial Transplant 21 2006 2282 2289 (Pubitemid 44295057)
21. RK Patel, S Oliver, PB Mark et al. Determinants of left ventricular mass and hypertrophy in haemodialysis patients assessed by cardiac magnetic resonance imaging Clin J Am Soc Nephrol 4 2009 1477 1483
22. H Holdaas, JA Kobashigawa, Fellstrom, AG Jardine Special transplant populations: transplant recipients CM Ballantyne Clinical lipidology 2009 Elsevier Philadelphia 486 499
23. H Holdaas, AG Jardine, DC Wheeler et al. The effect of fluvastatin on acute renal allograft rejection: a randomised multicentre trial Kidney Int 60 2001 1990 1997 (Pubitemid 33000006)
24. ES Woodle, MR First, J Pirsch, F Shihab, AO Gaber, P Van Veldhuisen for the Astellas Corticosteroid Withdrawal Study Group A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy Ann Surg 248 2008 564 577
25. TR Srinivas, HU Meier-Kriesche Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result Clin J Am Soc Nephrol 3 suppl 2 2008 S101 S116
26. KM Wissing, P Unger, L Ghisdal et al. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation Transplantation 82 2006 771 778 (Pubitemid 44470380)
27. RW Johnson, H Kreis, R Oberbauer, C Brattström, K Claesson, J Eris Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure Transplantation 72 2001 777 786 (Pubitemid 32879845)
28. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients Am J Transplant 9 suppl 3 2009 S1 155
29. FG Cosio, TE Pesavento, RP Pelletier et al. Patient survival after renal transplantation III: the effects of statins Am J Kidney Dis 40 2002 638 643 (Pubitemid 34971294)
30. CM Ballantyne, A Corsini, MH Davidson et al. Risk for myopathy with statin therapy in high-risk patients Arch Intern Med 163 2003 553 564 (Pubitemid 36314342)
31. JA Kobashigawa, S Katznelson, H Laks et al. Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 333 1995 621 627
32. RS Gaston, BL Kasiske, AM Fieberg et al. Use of cardioprotective medications in kidney transplant recipients Am J Transplant 9 2009 1811 1815
33. C Ponticelli, D Cucchiari, G Graziani Hypertension in kidney transplant recipients Transplant Int 24 2011 523 533
34. U Hillebrand, BM Suwelack, K Loley et al. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients Transplant Int 22 2009 1073 1080
35. G Opelz, T Wujciak, E Ritz Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study Kidney Int 53 1998 217 222 (Pubitemid 28066925)
36. G Heinze, C Mitterbauer, H Regele et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation J Am Soc Nephrol 17 2006 889 899
37. G Opelz, M Zeier, G Laux, C Morath, B Döhler No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report J Am Soc Nephrol 17 2006 3257 3262 (Pubitemid 44707788)
38. R Oberbauer, G Segoloni, JM Campistol for the Rapamune Maintenance Regimen Study Group Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation Transpl Int 18 2005 22 28 (Pubitemid 41742941)
39. G Opelz, B Döhler for the Collaborative Transplant Study Improved long-term outcomes after renal transplantation associated with blood pressure control Am J Transplant 5 2005 2725 2731
40. K Midtvedt, H Ihlen, A Hartmann et al. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study Transplantation 72 2001 107 111 (Pubitemid 32652514)
41. T Philipp, F Martinez, H Geiger et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET Nephrol Dial Transplant 25 2010 967 976
42. MK Shamseddin, GA Knoll Posttransplantation proteinuria: an approach to diagnosis and management Clin J Am Soc Nephrol 6 2011 1786 1793
43. VK Revanur, AG Jardine, DB Kingsmore, BC Jaques, DH Hamilton, RM Jindal Influence of diabetes mellitus on patient and graft survival in recipients of renal transplantation Clin Transplant 15 2001 89 94 (Pubitemid 32229796)
44. J Hjelmesaeth, A Hartmann, T Leivestad et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events Kidney Int 69 2006 588 595 (Pubitemid 43164454)
45. BL Kasiske, JJ Snyder, D Gilbertson, AJ Matas Diabetes mellitus after kidney transplantation in the United States Am J Transplant 3 2003 178 185 (Pubitemid 36323115)
46. EH Cole, O Johnston, CL Rose, JS Gill Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival Clin J Am Soc Nephrol 3 2008 814 821
47. RS Woodward, MA Schnitzler, J Baty et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients Am J Transplant 3 2003 590 598 (Pubitemid 36612842)
48. O Johnston, CL Rose, AC Webster, JS Gill Sirolimus is associated with new-onset diabetes in kidney transplant recipients J Am Soc Nephrol 19 2008 1411 1418
49. F Vincenti, S Friman, E Scheuermann for the DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus Am J Transplant 7 2007 1506 1514 (Pubitemid 46776239)
50. JP van Hooff, MH Christiaans, EM van Duijnhoven Tacrolimus and posttransplant diabetes mellitus in renal transplantation Transplantation 79 2005 1465 1469 (Pubitemid 40847574)
51. K Midtvedt, J Hjelmesaeth, A Hartmann et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal J Am Soc Nephrol 15 2004 3233 3239 (Pubitemid 39578856)
52. N Joss, CE Staatz, AH Thomson, AG Jardine Predictors of new onset diabetes after renal transplantation Clin Transplant 21 2007 136 143 (Pubitemid 46189598)
53. DM Zelle, PK Agarwal, JL Ramirez et al. Alcohol consumption, new onset of diabetes after transplantation, and all-cause mortality in renal transplant recipients Transplantation 92 2011 203 209
54. BL Kasiske, D Klinger Cigarette smoking in renal transplant recipients J Am Soc Nephrol 11 2000 753 759 (Pubitemid 30171885)
55. L Ghisdal, C Baron, Y Le Meur et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation J Am Soc Nephrol 20 2009 2459 2467
56. J Zuber, C Bellanné-Chantelot, C Carette et al. HNF1B-related diabetes triggered by renal transplantation Nat Rev Nephrol 5 2009 480 484
57. FL Luan, LJ Stuckey, AO Ojo Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation Transplantation 89 2010 1034 1039
58. A Wilkinson, J Davidson, F Dotta et al. Guidelines for the treatment and management of new-onset diabetes after transplantation Clin Transplant 19 2005 291 298 (Pubitemid 40711959)
59. S Abedini, I Holme, W März for the ALERT study group Inflammation in renal transplantation Clin J Am Soc Nephrol 4 2009 1246 1254
60. S Abedini, A Meinitzer, I Holme et al. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients Kidney Int 77 2010 44 50
61. JI Roodnat, EA van Gurp, PG Mulder et al. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation Transplantation 82 2006 362 367 (Pubitemid 44223035)
62. ES Schaeffner, M Födinger, R Kramar, G Sunder-Plassmann, WC Winkelmayer Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients Transpl Int 20 2007 247 255
63. C Rigatto Anemia, renal transplantation, and the anemia paradox Semin Nephrol 26 2006 307 312 (Pubitemid 44722450)
64. WC Winkelmayer, R Kramar, G Sunder-Plassmann, M Födinger Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients Kidney Int 68 2005 2857 2862 (Pubitemid 43251033)
65. G Heinze, A Kainz, WH Hörl, R Oberbauer Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study BMJ 339 2009 b4018
66. AG Bostom, MA Carpenter, JW Kusek et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial Circulation 123 2011 1763 1770
67. CN Kotton Management of cytomegalovirus infection in solid organ transplantation Nat Rev Nephrol 6 2010 711 721
68. C Baron, C Forconi, Y Lebranchu Revisiting the effects of CMV on long-term transplant outcome Curr Opin Organ Transplant 15 2010 492 498
69. KL Lentine, TC Villines, H Xiao et al. Cardioprotective medication use after acute myocardial infarction in kidney transplant recipients Transplantation 91 2011 1120 1126